感染指南

订阅

MedSci主页 / 所有栏目 / 感染指南

渗入式胸腔积液的管理：德尔菲共识声明

2020-06-01 Chest . 2020 Jun 16;S0012-3692(20)31676-7.

胸膜导管

背景：复发性胸腔积液的处理仍然是临床医生面临的挑战。复发性胸腔积液的管理对临床医生来说仍然是一个具有挑战性的问题。由于管理方面的进步导致了更多地使用留置隧道式胸膜导管（IPC），因为其有效性和门诊置管

中文标题：

渗入式胸腔积液的管理：德尔菲共识声明

发布机构：

发布日期：

2020-06-01

简要介绍：

背景：复发性胸腔积液的处理仍然是临床医生面临的挑战。复发性胸腔积液的管理对临床医生来说仍然是一个具有挑战性的问题。由于管理方面的进步导致了更多地使用留置隧道式胸膜导管（IPC），因为其有效性和门诊置管的方便性。然而，随着IPC置管量的增加，包括感染在内的并发症的报告也越来越多。目前，IPC置入后相关管理问题的指导意见很少。

研究问题。我们的目标是基于胸膜疾病管理专家的改良德尔菲过程，制定与围手术期和长期IPC导管管理相关的临床共识声明。

研究设计：和方法。专家小组成员利用修改后的德尔菲过程，就IPC使用相关的共同围手术期和长期管理方案达成共识。成员来自多个国家、专业和实践环境。一系列会议和匿名在线调查已经完成。使用修改后的Delphi过程，将答复用于制定小组专家之间的共识声明。共识被先验地定义为小组成员之间80%以上的一致意见。

结果。共有25名医生参加了这个项目。在此过程中涉及以下主题：IPC感染的定义、IPC相关感染性并发症的管理、预防IPC感染的干预措施、IPC相关梗阻/功能障碍的管理、IPC切除的评估以及患者和护理人员对IPC管理的指导。在36项陈述上取得了强烈的共识。有29项陈述未获得共识。

解释。复发性胸膜疾病与IPC的管理仍然是复杂和具有挑战性的。本声明在专家共识的基础上，提供了与留置隧道式胸膜导管管理相关的众多领域的护理陈述，并确定了缺乏共识的领域。与IPC的长期管理相关的进一步研究是有必要的。

相关资料下载：
[AttachmentFileName(sort=1, fileName=10.1200@JCO.20.00866.pdf)] GetToolGuiderByIdResponse(projectId=1, id=73eb01c00192a9c5, title=渗入式胸腔积液的管理：德尔菲共识声明, enTitle=, guiderFrom=Chest . 2020 Jun 16;S0012-3692(20)31676-7., authorId=0, author=, summary=背景：复发性胸腔积液的处理仍然是临床医生面临的挑战。复发性胸腔积液的管理对临床医生来说仍然是一个具有挑战性的问题。由于管理方面的进步导致了更多地使用留置隧道式胸膜导管（IPC），因为其有效性和门诊置管, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Jun 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>背景：复发性胸腔积液的处理仍然是临床医生面临的挑战。复发性胸腔积液的管理对临床医生来说仍然是一个具有挑战性的问题。由于管理方面的进步导致了更多地使用留置隧道式胸膜导管（IPC），因为其有效性和门诊置管的方便性。然而，随着IPC置管量的增加，包括感染在内的并发症的报告也越来越多。目前，IPC置入后相关管理问题的指导意见很少。</p> <p>研究问题。我们的目标是基于胸膜疾病管理专家的改良德尔菲过程，制定与围手术期和长期IPC导管管理相关的临床共识声明。</p> <p>研究设计：和方法。专家小组成员利用修改后的德尔菲过程，就IPC使用相关的共同围手术期和长期管理方案达成共识。成员来自多个国家、专业和实践环境。一系列会议和匿名在线调查已经完成。使用修改后的Delphi过程，将答复用于制定小组专家之间的共识声明。共识被先验地定义为小组成员之间80%以上的一致意见。</p> <p>结果。共有25名医生参加了这个项目。在此过程中涉及以下主题：IPC感染的定义、IPC相关感染性并发症的管理、预防IPC感染的干预措施、IPC相关梗阻/功能障碍的管理、IPC切除的评估以及患者和护理人员对IPC管理的指导。在36项陈述上取得了强烈的共识。有29项陈述未获得共识。</p> <p>解释。复发性胸膜疾病与IPC的管理仍然是复杂和具有挑战性的。本声明在专家共识的基础上，提供了与留置隧道式胸膜导管管理相关的众多领域的护理陈述，并确定了缺乏共识的领域。与IPC的长期管理相关的进一步研究是有必要的。</p>, tagList=[TagDto(tagId=104459, tagName=胸膜导管)], categoryList=[CategoryDto(categoryId=9, categoryName=感染, tenant=100), CategoryDto(categoryId=24, categoryName=胸心外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3462, appHits=225, showAppHits=0, pcHits=556, showPcHits=3237, likes=2, shares=8, comments=9, approvalStatus=1, publishedTime=Tue Jun 23 17:37:46 CST 2020, publishedTimeString=2020-06-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Tue Jun 23 17:37:39 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 19:58:20 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=10.1200@JCO.20.00866.pdf)])
10.1200@JCO.20.00866.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1197269, encodeId=25cf119e269be, content=很好很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46d35553026, createdName=msly4, createdTime=Fri Feb 25 17:22:44 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971036, encodeId=d56a9e1036c3, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:07:11 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908332, encodeId=b434908332d7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=坚持本心, createdTime=Tue Dec 15 22:12:01 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898586, encodeId=3c2b89858672, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=Rhonda, createdTime=Wed Nov 11 23:28:58 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898579, encodeId=b2908985e9c1, content=很好很好h, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=14895ef1m75暂无昵称, createdTime=Wed Nov 11 23:09:30 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2022-02-25 msly4

    很好很实用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1197269, encodeId=25cf119e269be, content=很好很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46d35553026, createdName=msly4, createdTime=Fri Feb 25 17:22:44 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971036, encodeId=d56a9e1036c3, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:07:11 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908332, encodeId=b434908332d7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=坚持本心, createdTime=Tue Dec 15 22:12:01 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898586, encodeId=3c2b89858672, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=Rhonda, createdTime=Wed Nov 11 23:28:58 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898579, encodeId=b2908985e9c1, content=很好很好h, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=14895ef1m75暂无昵称, createdTime=Wed Nov 11 23:09:30 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2021-06-05 124d1424m59暂无昵称

    很实用

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1197269, encodeId=25cf119e269be, content=很好很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46d35553026, createdName=msly4, createdTime=Fri Feb 25 17:22:44 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971036, encodeId=d56a9e1036c3, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:07:11 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908332, encodeId=b434908332d7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=坚持本心, createdTime=Tue Dec 15 22:12:01 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898586, encodeId=3c2b89858672, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=Rhonda, createdTime=Wed Nov 11 23:28:58 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898579, encodeId=b2908985e9c1, content=很好很好h, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=14895ef1m75暂无昵称, createdTime=Wed Nov 11 23:09:30 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-12-15 坚持本心

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1197269, encodeId=25cf119e269be, content=很好很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46d35553026, createdName=msly4, createdTime=Fri Feb 25 17:22:44 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971036, encodeId=d56a9e1036c3, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:07:11 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908332, encodeId=b434908332d7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=坚持本心, createdTime=Tue Dec 15 22:12:01 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898586, encodeId=3c2b89858672, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=Rhonda, createdTime=Wed Nov 11 23:28:58 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898579, encodeId=b2908985e9c1, content=很好很好h, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=14895ef1m75暂无昵称, createdTime=Wed Nov 11 23:09:30 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-11-11 Rhonda

    好好好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1197269, encodeId=25cf119e269be, content=很好很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46d35553026, createdName=msly4, createdTime=Fri Feb 25 17:22:44 CST 2022, time=2022-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=971036, encodeId=d56a9e1036c3, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ff5b2517502, createdName=124d1424m59暂无昵称, createdTime=Sat Jun 05 08:07:11 CST 2021, time=2021-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=908332, encodeId=b434908332d7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/12/05/15705d7598138cc7989bb8eb6f8dc08b.jpg, createdBy=28422215610, createdName=坚持本心, createdTime=Tue Dec 15 22:12:01 CST 2020, time=2020-12-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898586, encodeId=3c2b89858672, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=Rhonda, createdTime=Wed Nov 11 23:28:58 CST 2020, time=2020-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=898579, encodeId=b2908985e9c1, content=很好很好h, beContent=null, objectType=guider, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ab195314782, createdName=14895ef1m75暂无昵称, createdTime=Wed Nov 11 23:09:30 CST 2020, time=2020-11-11, status=1, ipAttribution=)]
    2020-11-11 14895ef1m75暂无昵称

    很好很好h

    0